Investigation of Circulating MicroRNA Levels in Antibody-Mediated Rejection After Kidney Transplantation

被引:1
|
作者
Nagy, Peter Ferenc [1 ]
Pocsi, Marianna [2 ]
Fejes, Zsolt [2 ]
Bidiga, Laszlo [3 ]
Szabo, Eszter [1 ]
Balogh, Orsolya [1 ]
Szollosi, Gergo Jozsef [4 ]
Nagy, Bela, Jr. [2 ]
Nemes, Balazs [1 ]
机构
[1] Univ Debrecen, Fac Med, Inst Surg, Dept Organ Transplantat, Debrecen, Hungary
[2] Univ Debrecen, Fac Med, Dept Lab Med, Debrecen, Hungary
[3] Univ Debrecen, Fac Med, Dept Pathol, Debrecen, Hungary
[4] Univ Debrecen, Fac Publ Hlth, Dept Intervent Epidemiol, Debrecen, Hungary
关键词
EXPRESSION;
D O I
10.1016/j.transproceed.2022.10.044
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. One of the most important possible complications determining long-term graft survival after kidney transplant is antibody-mediated rejection (ABMR). The criterion standard approach to recognize ABMR is currently the kidney biopsy with histopathologic analysis. However, this test has limitations because of difficulties in timing of sampling, the evaluability of histology because of the questionable representativeness of specimens, and the limited number of this intervention. Hence, new reliable, noninvasive biomarkers are required to detect the development of ABMR in time. Methods. In this study, we analyzed the clinical data of 45 kidney transplant patients (mean age of 44.51 years, 20 male and 25 female subjects). These participants were recruited into 5 subcohorts based on their clinical status, histologic findings, and level of donor-specific anti-HLA antibodies. Circulating microRNAs (miR-21, miR-181b, miR-146a, miR-223, miR-155, miR-150) in plasma samples were quantified by quantitative polymerase chain reaction and their levels were correlated with the clinical characteristics in different subgroups. Results. The relative expression of plasma miR-155 (P = .0003), miR-223 (P = .0316), and miR-21 (P = .0147) were significantly higher in patients who had subsequent histology-approved ABMR with donor-specific anti-HLA antibody positivity (n = 10) than in the "triple negative" group (n = 21), and miR-155 showed the highest sensitivity (90%) and specificity (81%) to indi-cate ABMR development based on receiver operating characteristic analysis. Conclusions. According to our preliminary data, plasma miR-155, miR-21, and miR-223 can indicate the development of ABMR after kidney transplant in correlation with classic clinical parameters. However, future studies with larger number of participants are necessary to further evaluate the diagnostic properties of blood miRNAs in prediction of this life-threatening condition.
引用
收藏
页码:2570 / 2577
页数:8
相关论文
共 50 条
  • [31] Antibody-Mediated Rejection (AMR) after Pancreas and Pancreas-Kidney Transplantation
    Rangel, Erika B.
    Malheiros, Denise M. A. C.
    Castro, Maria Cristina R.
    Antunes, Irina
    Torres, Margareth A.
    Crescentini, Fabio
    Genzini, Tercio
    Perosa, Marcelo
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 6 - 6
  • [32] Gut microbiota alterations associated with antibody-mediated rejection after kidney transplantation
    Wang, Junpeng
    Li, Xin
    Wu, Xiaoqiang
    Wang, Zhiwei
    Zhang, Chan
    Cao, Guanghui
    Liu, Shun
    Yan, Tianzhong
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2021, 105 (06) : 2473 - 2484
  • [33] Gut microbiota alterations associated with antibody-mediated rejection after kidney transplantation
    Junpeng Wang
    Xin Li
    Xiaoqiang Wu
    Zhiwei Wang
    Chan Zhang
    Guanghui Cao
    Shun Liu
    Tianzhong Yan
    Applied Microbiology and Biotechnology, 2021, 105 : 2473 - 2484
  • [34] GUT MICROBIOTA ALTERATIONS ASSOCIATED WITH ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION
    Wang, Junpeng
    Wu, Xiaoqiang
    Yan, Tianzhong
    TRANSPLANTATION, 2020, 104 (09) : S191 - S191
  • [35] REVISITING THE CHANGES IN THE BANFF CLASSIFICATION FOR ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION
    Callemeyn, Jasper
    Ameye, Heleen
    Lerut, Evelyne
    Senev, Aleksandar
    Coemans, Maarten
    Van Loon, Elisabet
    Sprangers, Ben
    Van Sandt, Vicky
    Rabeyrin, Maud
    Dubois, Valerie
    Thaunat, Olivier
    Kuypers, Dirk
    Emonds, Marie-Paule
    Naesens, Maarten
    TRANSPLANT INTERNATIONAL, 2021, 34 : 160 - 161
  • [36] Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation
    Callemeyn, Jasper
    Ameye, Heleen
    Lerut, Evelyne
    Senev, Aleksandar
    Coemans, Maarten
    Van Loon, Elisabet
    Sprangers, Ben
    Van Sandt, Vicky
    Rabeyrin, Maud
    Dubois, Valerie
    Thaunat, Olivier
    Kuypers, Dirk
    Emonds, Marie-Paule
    Naesens, Maarten
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (07) : 2413 - 2423
  • [37] The efficacy of deoxyspergualin and plasmapheresis for antibody-mediated acute rejection after kidney transplantation
    Nojima, MM
    Yoshimoto, T
    Nakao, A
    Maruyama, T
    Takiuchi, H
    Hashimoto, M
    Kyo, M
    Shima, H
    JOURNAL OF UROLOGY, 2004, 171 (04): : 494 - 494
  • [38] Antibody-mediated rejection in the kidney
    Racusen, LC
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (03) : 768 - 769
  • [39] Antibody-mediated rejection (AMR) after pancreas and pancreas-kidney transplantation
    Rangel, Erika B.
    Malheiros, Denise M. A. C.
    Ribeiro de Castro, Maria Cristina
    Antunes, Irina
    Torres, Margareth A.
    Crescentini, Fabio
    Genzini, Tercio
    Perosa, Marcelo
    TRANSPLANT INTERNATIONAL, 2010, 23 (06) : 602 - 610
  • [40] Management of antibody-mediated rejection after kidney transplantation in our clinical practice
    Reka, P. Szabo
    Hashmi, Amna Jousaf
    Nikolett, KOti
    Aniko, Szilvasi
    Laszlo, Bidiga
    Laszlo, Kardos
    Lajos, Zsom
    Jozsef, Balla
    Balazs, Nemes
    ORVOSI HETILAP, 2021, 162 (26) : 1029 - 1037